Self-Pay Options For patients without B12 coverage, or those getting injections for general wellness, we often have cost-saving options available
Research indicates that more than $500 million claims were denied due to inaccurate coding of therapeutic injections
Each component is not FDA-approved and was removed from 503B bulk-compounding eligibility in 2024
Reply within one working day About the author Alaiyka Parvez Owner, CoLaz Aesthetics Clinic Alaiyka Parvez bought the CoLaz franchise network in 2023, having joined the company as a Slough clinic employee in 2013 and gone on to open the Hounslow and Wembley franchises
We are confident we have the best prices, but in case you find better, we'll price match
BPC-157 is a synthetic peptide studied in laboratory and peptide research involving cellular signaling pathways and tissue-related research applications